Clinical Trial Update: A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing levofloxacin with imipenem/cilastatin for safety and effectiveness in hospital-acquired pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia

Drugs mentioned

• Levaquin (levofloxacin)
• Primaxin (imipenem/cilastatin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Nosocomial Pneumonia | Phase 3 | Status: COMPLETED